High BMI is significantly associated with positive progesterone receptor status and clinico-pathological markers for non-aggressive disease in endometrial cancer

Role of body mass index as a risk and prognostic factor of endometrioid uterine cancer in Korean women

(2010) Nan-Hee Jeong et al.   GYNECOLOGIC ONCOLOGY

Role of Progesterone in Endometrial Cancer

(2010) J. Kim et al.   SEMINARS IN REPRODUCTIVE MEDICINE

Biologic markers in endometrial cancer treatment

(2009) INGEBORG B ENGELSEN et al.   APMIS

Association of the progesterone receptor gene with endometrial cancer risk in a Chinese population

(2009) Wang-Hong Xu et al.   CANCER

Integrated genomic profiling of endometrial carcinoma associates aggressive tumors with indicators of PI3 kinase activation

(2009) H. B. Salvesen et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

GATA3 expression in estrogen receptor α-negative endometrial carcinomas identifies aggressive tumors with high proliferation and poor patient survival

(2008) Ingeborg B. Engelsen et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

Low BMI-1 expression is associated with an activated BMI-1-driven signature, vascular invasion and hormone receptor loss in endometrial carcinoma

(2008) I B Engelsen et al.   BRITISH JOURNAL OF CANCER

Body mass, diabetes and smoking and endometrial cancer risk: a follow-up study

(2008) K Lindemann et al.   BRITISH JOURNAL OF CANCER

Influence of body mass index on prognosis in gynecological malignancies

(2008) Karsten Münstedt et al.   CANCER CAUSES & CONTROL